PDF) Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions The REALITY Trial: A Randomized Controlled Trial
Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy
De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation
PDF] Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes?
HeartSciences $HSCS #AI #ECG on X: 🚨 News: HeartSciences provides business update and reports second quarter fiscal 2023 financial results – Patient enrollment close to completion and continue to target FDA De
CRT Upgrade Procedures Deliver Outcomes Similar to New CRT Implants With No Excess Complications – Consult QD
Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block - ScienceDirect
Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block - ScienceDirect
TCT-119 Procedural and Clinical Outcomes of IS-CTO and De Novo CTO PCIs
Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock - ScienceDirect
De Novo Heart Failure & Acute Decompensated Chronic Heart Failure
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review
Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation - ScienceDirect
Full article: Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications
JCM, Free Full-Text